AG
TMO icon

AIA Group’s Thermo Fisher Scientific TMO Stock Holding History

AIA Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.6M Sell
86,693
-5,759
-6% -$3.13M 0.62% 24
2025
Q4 		$53.6M Buy
92,452
+53,152
+135% +$30.1M 0.8% 21
2025
Q3 		$19.1M Buy
39,300
+12,885
+49% +$6M 0.34% 43
2025
Q2 		$10.7M Buy
26,415
+3,309
+14% +$1.38M 0.23% 57
2025
Q1 		$11.5M Buy
23,106
+4,342
+23% +$2.35M 0.28% 51
2024
Q4 		$9.76M Buy
18,764
+1,088
+6% +$598K 0.24% 51
2024
Q3 		$10.9M Buy
17,676
+309
+2% +$183K 0.28% 49
2024
Q2 		$9.6M Buy
17,367
+2,146
+14% +$1.23M 0.28% 46
2024
Q1 		$8.85M Buy
15,221
+773
+5% +$434K 0.29% 40
2023
Q4 		$7.67M Buy
14,448
+3,568
+33% +$1.73M 0.31% 42
2023
Q3 		$5.51M Sell
10,880
-1,969
-15% -$1.05M 0.27% 48
2023
Q2 		$6.7M Buy
12,849
+9,322
+264% +$5.03M 0.32% 39
2023
Q1 		$2.03M Buy
3,527
+262
+8% +$148K 0.11% 87
2022
Q4 		$1.8M Sell
3,265
-233
-7% -$123K 0.11% 79
2022
Q3 		$1.77M Buy
3,498
+402
+13% +$225K 0.12% 78
2022
Q2 		$1.68M Sell
3,096
-2,290
-43% -$1.26M 0.09% 93
2022
Q1 		$3.18M Buy
5,386
+2,645
+96% +$1.52M 0.14% 64
2021
Q4 		$1.83M Buy
2,741
+2,257
+466% +$1.41M 0.09% 101
2021
Q3 		$277K Buy
484
+38
+9% +$20.9K 0.02% 229
2021
Q2 		$233K Sell
446
-2,586
-85% -$1.22M 0.02% 202
2021
Q1 		$1.38M Buy
3,032
+1,794
+145% +$856K 0.2% 72
2020
Q4 		$619K Buy
+1,238
New +$580K 0.07% 107

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIA Group's TMO Position: Q1 2026 in Review

AIA Group reduced its Thermo Fisher Scientific (TMO) stake by 6.2% in Q1 2026, selling an estimated $3.13M and leaving 86,693 shares worth $42.6M. The position accounts for 0.62% of the portfolio, ranked #24.

AIA Group first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $53.6M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • AIA Group held 86,693 shares of Thermo Fisher Scientific worth $42.6M as of Q1 2026.
  • AIA Group sold 5,759 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.13M.
  • Thermo Fisher Scientific made up 0.62% of AIA Group's portfolio in Q1 2026, its #24 holding.
  • AIA Group first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
  • AIA Group's Thermo Fisher Scientific position peaked at $53.6M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.